imaging (MRI) (5). However, TRUS is the most widely employed imaging modality for PA and the best technique executable in a short time, with low radiant exposure, and low costs at detecting smaller abscess (6). To date, in the literature there is no specific classification based on imaging, and clinical aspects of different types of prostatic abscess. In this study we present a review of PA ultrasound imaging and propose a new classification of PA related to clinical features of the patients.
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MATERIALS AND METHODS
We retrospectively analysed the ultrasound database at our Department of Urology, which contains the stored images of 4000 cases from August 2007 to December 2014. Only 1300 of these images (33%) are TRUS to study prostate diseases. All cases were evaluated by an expert urologist (LD). Each patient was treated under local anesthesia with lidocaine spray (10 gr/100 ml), applied two minutes before the TRUS (7). The procedure was performed with the patient in the left lateral decubitus using a General Electric Logiq 7 equipped with a 5-9 MHz multi-frequency convex probe "end-fire". Each TRUS examination included an assessment of the prostatic diameter, the measurement of the whole prostate volume, and the evaluation of the transition zone, capsular and seminal vesicle characteristics, as well as the morphological description of potential pathological features. On 1 January, 2015 a MEDLINE ® search of the peer reviewed literature on diagnosis and case reports of PA was done using the terms "prostate and abscess" . A total of 47 papers were evaluated. We propose a classification of prostatic abscess into 5 distinct types according to the literature and validated by our experience.
RESULTS

Type I -Prostatic abscess is present focally in a prostate lobe (≤ 10 mm).
If the prostatic abscess interests focally (≤ 10 mm) one prostate lobe (Type I), frequently is present also in the transition zone and in the central zone of the prostate (2, 4) . We can divide it into three subtypes (IA, IB and IC) on the basis of ultrasonography (US) pattern and the type of clinical symptoms. In the subtype IA, PA presents a discrete low echoic or anechoic area with irregular contour. This contour shows along the outermost periphery
INTRODUCTION
Prostatic abscess (PA) in an unusual condition with an incidence of about 0.5% of all prostatic disorders (1). This prostatic disease is thought to arise most commonly as a consequence of inadequately treated acute bacterial prostatitis. Other causes include bladder outlet obstruction such as: benign prostatic hypertrophy, indwelling urethral catheters and lower urinary tract invasive procedures as prostate biopsy (2, 3) . Immunosuppressed states and diabetes mellitus predispose to the formation of PA (4) . The signs and symptoms of PA are non-specific and include urinary retention, dysuria, a palpably enlarged and tender prostate gland, and fever. Several studies employed in PA diagnosis include transrectal ultrasound (TRUS), computed tomography (CT) scanning, or magnetic resonance a diffuse enlargement with a homogeneous low level of echogenicity due to oedema and inflammatory cell infiltration. This subtype of PA is incidentally diagnosed during a routine ultrasound for diagnostic purposes or follow-up for different urologic problems (urinary retention, urinary tract infection, chronic indwelling catheter, prostate biopsy). These subtypes must be differentiated from the prostatic retention cyst, which is frequently (0.5-7.9%) observed in the gland as an isolated lesion surrounded by normal tissue. Ultrasound features are an anechoic content (less than 8 mm diameter) with thin and smooth walls or threadlike septa (8) .
In the subtype IB, PA presents a non-homogeneous content with well-defined edges and/or irregular contour (with possible thickened aspect for homogeneous low level echogenicity or hyperechoic structure). This nonhomogeneous content like fluid material within prostatic abscess shows a movement by changing the position of the patient. In the antibiotic era, Gram-negative bacilli (mainly E. coli) cause about 60 to 80% of cases. Other significant pathogens include Pseudomonas species, Staphylococcus species, and occasionally obligate anaerobic bacteria (9) . In the subtype IC, PA can appear with the characteristics of both types IA and IB, but is diagnosed to detect a potential PA following the appearance of nonspecific symptoms such as hematuria, hemospermia, lower urinary tract symptoms (LUTS), urinary retention and fever. This subtype is the most frequent because of its clinical presentation during the fifth or sixth decade of life and constitutes approximately 0.5-1% of patients hospitalized for prostatic disorders (10) . Often Type I is considered to be a sequel of an acute o chronic prostatitis that has either not been treated or that has been treated inappropriately (11) .
Type II -Prostatic abscess is present in a prostate lobe (> 10 mm) and/or partially overcrosses the midline prostatic glandular border. If the prostatic abscess interests one prostate lobe (> 10 mm) focally or overcrosses the midline prostatic glandular border (Type II), it can be frequently located in the transition zone, as well as in the peripheral zone of the gland (5, 12) . We can divide it into three subtypes (IIA, IIB and IIC) on the basis of US pattern and the type of clinical symptoms. The subtypes IIA and IIB have the same ultrasound pattern of subtypes IA and IB, although dimensions are ≥ 10 mm and/or extended in the contralateral part of the prostate gland ( Figure 1A, B) . These PA subtypes are diagnosed incidentally during a routine ultrasound. In the subtype IIC, PA can appear with the characteristics of both subtypes IIA and IIB, but it is diagnosed to detect a potential PA following the appearance of nonspecific symptoms such as hematuria, hemospermia, LUTS, urinary retention, dysuria, a palpably enlarged and tender prostate gland, fever, and sepsis. Subtypes IC and IIC are more often haemorrhages rather than infectious prostate biopsy's complication. Hemorragic post-biopsy PA are rare with an incidence of 1.3% (12). It is not possible to differentiate by TRUS the sonographic distinctive features of the two conditions, although often the patient's medical history or a multiparametric MRI are helpful.
Type III -Prostatic abscess is present in both glandular lobes form of multifocal areas (≤ 10 mm). If PA interests both glandular lobes by two or more multifocal areas each of size ≤ 10 mm (Type III), we can divide it into two subtypes (IIIA, IIIB) on the basis of ultrasound pattern and of clinical symptoms (Figure 2 ). In the subtype IIIA, PA presents a hypoechoic or anechoic or non-homogeneous content with irregular rim (possible thickened aspect or hyperechoic echostructure). This subtype of PA is diagnosed incidentally during a routine ultrasound. In Type IIIB, PA can appear with the US patterns of subtype IIIA, but this subtype is diagnosed to detect a potential PA following the appearance of symptoms (hematuria, hemospermia, LUTS, urinary retention) or in the case of painful and palpably tender prostate gland. This subtype is the most frequent cause of clinical presentation of granulomatous prostatitis. The exact aetiology of granulomatous prostatitis remains unclear and in many cases it may be idiopathic (13), although it can be also caused by several specific (as Mycobacterium tuberculosis) (14) and non-specific infectious agents. It can also be secondary to prostatic surgery such as transurethral resection (15) . However, the areas of abnormally low hypoechoic or non-homogeneous structure occurring in granulomatous prostatitis have no characteristic ultrasonography pattern to differentiate them from cancer and histological confirmation is necessary to obtain a definitive diagnosis (16) . 
Type IV -Prostatic abscess is present in both glandular lobes form of multifocal areas (> 10 mm).
If PA interests both glandular lobes by two or more multifocal areas each of size > 10 mm (Type IV). This type can be divided in the IV A and IV B according to the appearance of the clinical symptoms. The most common TRUS finding in all patients was the detection of a hypoechoic area with non-homogeneous structure. In some patients irregular contour and hyperechoic areas were additionally described (17) . In literature and in our experience the PA Type IV is related to a massive caseous necrosis induced in patients that had received intravesical instillations of Bacillus Calmette-Guerin (BCG) for superficial bladder tumor (18) (19) (20) .
Type V -Prostatic abscess involving intra or extraprostatic structures (bladder, urethra, seminal vesicles and prostatic capsule).
If the prostatic abscess, regardless of its size, presents compressive phenomena involving intra or extraprostatic structures as bladder, urethra, seminal vesicles and/or prostatic capsule (Type V), it always causes clinical symptoms due to extrinsic compression (6) of the structures listed as: hemospermia, hematuria, purulent urethral secretions, urinary retention, dysuria, incomplete bladder emptying or urinary urgency, and sometimes fever. Although fluctuation to the rectum should make one suspect abscess, this is not a constant finding, as in the case of para-urethral or bladder localization (Figure 3) . Treatment of PA implied parental broad-spectrum antibiotic administration and/or abscess drainage. This may be performed, depending on its localization by transrectal or transperineal ultrasound, by perineal route, transurethral incision or resection of the prostate, or open perineal drainage (2).
DISCUSSION
PA is uncommon and difficult to diagnose because initial clinical presentation may mimic several other diseases of the lower urinary tract. Its incidence has markedly decreased for the widespread use of antibiotics (9) . PA should be suspected in patients presenting with fever and persistent LUTS that do not respond to antibiotics. Predisposing factors for the development of PA are diabetes mellitus, bladder outlet obstruction, indwelling catheter, prostate biopsy, chronic renal failure, chronic liver disease and HIV infection (2, 21) . The diagnosis and localization of PA have been facilitated with the advent of TRUS (22) . Transabdominal ultrasonography is usually not sufficient to make a diagnosis because it does not delineate the anatomical details of PA, owing to its peripheral glandular location or to the physical constitution of the patient. TRUS can exactly define the localization, number and size of PA and help in the management and follow-up. However, according to some authors TRUS is not feasible in all patients as it is highly painful in presence of PA, and MRI or CT scan are more suitable to define the disease (23) . In our experience the use of local anesthesia with lidocaine spray, allowed to perform TRUS in all patients in a comfortable way, except in a few conditions that might be a contraindication such as in patients with severe haemorrhoids or anal fistulas or submitted abdominoperineal resection (7) . The most common finding of PA is a hypoechoic or anechoic lesion with more or less defined edges and a peripheral hyperechoic halo. A remarkable finding is the alteration of prostate ultrasound anatomy. However, a differential diagnosis must be made for a similar ultrasound appearance of tumors, cystic lesions, and focal acute prostatitis (8) . Prostatic imaging with CT and MRI is important in the differential diagnosis of PA. Some studies shown that the more cost-effective CT and MRI hold no advantage over TRUS unless the abscess has penetrated the confines of the prostate (Type V) or there are further abscess foci suspected (24, 25) . Therefore, a histological confirmation is necessary to obtain a definitive diagnosis in doubtful cases. TRUS is the most widely used technique in the guide for percutaneous aspiration or PA biopsy and in evaluation of response to treatment (1, 2, 4, 9) . In this study the classification of PA into five distinct types proposed is based on ultrasonography pattern and clinical evidence of the disease as reported in numerous studies. However, most published data regarding PA are case reports, and there is no standardization of the diagnostic and therapeutic routines. In review articles, the summary of several individual experiences permits to delineate some lines of action for PA. In the literature, few authors as Lim et al. (25) or Gorus et al. (26) tried to classify the pathology based on the ultrasound images acquired with TRUS but with the purpose to standardize a treatment of percutaneous aspiration rather than a clinical and ultrasonographic classification of the disease. Barozzi et al. (27) described the sonographic features of their patients related to bacterial etiology after abscess drainage of the gland, but not making a standardized imaging classification. Limitations of this classification could perhaps be identified in the lack of comparison with pathological features after biopsy. Additional studies with more detailed exposure measurement are warranted to evaluate questions about ultrasound imaging, pathology features, etiology and the best management for the treatment and therapy duration.
CONCLUSIONS
In last years prostatic imaging modalities (TRUS, CT and MRI) gained a wide acceptance in diagnosis of PA. Of these imaging modalities TRUS is widely used in diagnosis of PA for the low cost and low radiation exposure (28) . The sonographic pattern of PA is usually characteristic and easily differentiated from other glandular lesions. The purpose of the study was to associate the use of TRUS to a clinical classification standardized to facilitate the diagnosis and localization of PA in order to direct the clinician to the correct management and adequate therapeutic treatment. Other studies will be required to verify its validity and clinical utility and to implement it.
